CXCL12 and neoplasm: By secreting CXCL12/SDF1, CAFs recruit monocytes to the tumor site, which are then induced to differentiate into MDSCs through IL-6-mediated STAT3 activation, thus altering CAR-T cell proliferation and function and diminishing their therapeutic effect (137).